STOCKSCREENR
Log In

PSNL

NASDAQ

Personalis, Inc.

$7.12+0.33(+4.86%)Mkt Cap: $632.29M

Key Stats

Market Cap

$632.29M

P/E Ratio

-7.82

EPS

$-0.91

Dividend Yield

0.00%

52-Week Range

$2.83 — $11.50

Volume

733.22K

Avg Volume

1.42M

Beta

2.11

Valuation

P/E (TTM)

-7.82

Forward P/E

—

PEG Ratio

2.24

P/S (TTM)

8.57

P/B (TTM)

2.37

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.39%

ROA (TTM)

-0.24%

ROIC

—

Gross Margin

0.23%

Operating Margin

-1.26%

Net Margin

—

Debt/Equity

0.12

Current Ratio

6.76

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.06%

EPS Growth (5Y)

-0.06%

Sales Growth (3Y)

+0.01%

Sales Growth (5Y)

+0.07%

EPS Est (This Year)

$-0.97

EPS Est (Next Year)

$-0.79

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$2.60

Analyst Consensus

Price Target Range

$10.00$11.00$13.00
LowMedianHigh

Consensus Target: $11.25(58.0% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

88.80M

Float

52.62M

Free Float %

59.25%

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NASDAQ

IPO Date

2019-06-20

Employees

228

CEO

Christopher Hall

Index Membership

—

Website

https://www.personalis.com

Personalis, Inc. (PSNL) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $632.29M, a P/E ratio of -7.82, PSNL is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PSNL against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NEO

NeoGenomics, Inc.

$8.27

+0.36%

$214.71M

GRAL

GRAIL, Inc.

$47.37

+3.54%

$1.91B

MYGN

Myriad Genetics, Inc.

$4.78

+4.14%

$446.97M

EDT.TO

Spectral Medical Inc.

$1.28

+2.34%

$370.10M

IDHC.L

Integrated Diagnostics Holdings plc

$0.58

-1.27%

$340.08M

TWST

Twist Bioscience Corporation

$47.28

+5.04%

$2.90B

Frequently Asked Questions

What is Personalis, Inc.'s P/E ratio?

Personalis, Inc. (PSNL) has a trailing twelve-month (TTM) P/E ratio of -7.82. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Personalis, Inc. pay a dividend?

No, Personalis, Inc. (PSNL) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Personalis, Inc.'s market cap?

Personalis, Inc. (PSNL) has a market capitalization of $632.29 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.